**10. Quality of life**

Déziel et al. investigated the impact of HBS treatment on health-related quality of life (Deziel et al., 2007). They included 44 patients who were partially hypertensive and/or hypotension-prone in a 6-month randomised controlled trial comparing standard HD and HBS. Quality of life was assessed using the Kidney Disease and Quality of Life Short Form (KDQOL-SF) questionnaire. There was a significant improvement in the burden of

Fig. 7. Decrease of antihypertensive drug and end dialysis body weight over 48 months of follow-up.

Blood Volume Regulation 249

Cavalcanti S, Ciandrini A, Severi S, Badiali F, Bini S, Gattiani A, Cagnoli L, Santoro A,

compensatory response to hypovolemia, Kidney Int, 2004, 65, 1499-1510. Dasselaar JJ, Huisman RM, De Jong PE, Burgerhof JGM, Franssen CFM. Effects of relative

Dasselaar JJ, Relative blood volume based biofeedback during dialysis, J of renal Care, 2007,

Davenport A, Cox C, Thuraisingham R. Achieving blood pressure targets during dialysis

Déziel C, Bouchard J, Zellweger M, Madore F. Impact of Hemocontrol on hypertension,

Franssen CFM, Dasselaar JJ, Sytsma P, Burgerhof JGM, De Jong PE, Huisman RM.

Iseki K, Miyasato F, Tokuyama K, ey al, Low diastolic blood pressure, hypoalbuminemia,

Kooman J, Basci A, Pizzarelli F, et al EBPG guideline on hemodynamic instability, Nephrol

Locatelli F, Buoncristiani U, Canaud B, et al, Haemodialysis with on-line monitoring

Mancini E, Santoro A, Spongano M, Paolini F, Zucchelli P, Effects of automatic blood

McIntyre CW, Lambie SH, Fluck RJ. Biofeedback controlled hemodialysis (BF-HD) reduces

global and segmental myocardial blood flow, Clin J Am Soc, 2008, 3, 19-26. Moret K, Aalten J, Van den Wall Bake W et al. The effect of sodium profiling and feedback

Paolini F, Bosetto A, Biofeedback system architecture, Adv in Renal Repl Therapy, 1999, 6, 3,

Pastore C, Ruggeri G, Pastore A, Siliberto P, Cristofaro V, Daily use of the physio dialysis system: long-term experience, EDTNA/ERCA J, 2002, XXVIII, 2, 16-20. Port, FK, Hulbert-Shearon TE, Wolfe RA, et al., Predialysis blood pressure and mortality risk

non-hypotension prone stable patients. Clin Nephrol, 2003; 60: 105-112. McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker C, Camici P,

equipment: tool or toys? Nephrol Dial Tranpslant, 2005, 20, 22-33.

hypertensive patients. ASAIO Journal 2007; 53: 357-364.

XXXIII, 2, 59-65.

Soc Nephrol 2007; 2: 661-668.

Dial & Transplan, 2007, 22, S2, i22-i44.

764.

9: 383-392.

1212-17.

18, 6, 495-498.

270-274.

255-264.

33 (3), 507-517.

Model-based study of the effects of the hemodialysis technique on the

blood volume-controlled hemodialysis on blood pressure and volume status in

improves control but increases intradialytic hypotension. Kidney Int 2008; 73: 759–

nursing interventions, and quality of life: a randomized controlled trial. Clin J Am

Automatic feedback control of relative blood volume changes during hemodialysis improves blood pressure stability during and after dialysis. Hemodialysis Int 2005;

and risk of death in a cohort of chronic hemodialysis patients, Kidney Int. 1997, 51,

volume control over intradialytic hemodynamic stability, Int J Artif Organs, 1995,

symptoms and increases both hemodynamic tolerability and dialysis adequacy in

Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in

technologies on plasma conductivity and ionic mass balance: a study in hypotension-prone dialysis patients. Nephrol Dial Transplant 2006; 21: 138-144. Nesrallah GE, Suri RS, Thiessen-Philbrook H, Heidenheim P, Lindsay RM. Can extracellular

fluid volume expansion in hemodialysis patients be safely reduced using the Hemocontrol biofeedback algorithm? A randomized trial. ASAIO Journal 2008; 54:

in a national sample of maintenance hemodialysis patients, Am J Kidney Dis, 1999,

kidney disease score in the HBS group, while there was a decrease in the control group (*P*=0.004). There was no other significant variation in quality-of-life items during the study. In another randomised trial comparing 6-month HD vs HBS treatment, a validated dialysis-related symptoms questionnaire was used to assess dialysis-related quality of life (Neshrallah et al., 2008). This questionnaire asked patients to rate the frequency and severity of dizziness, fatigue, muscle cramps, and other symptoms. None of these differed significantly between groups over time.
